Jacqueline M Mason

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Tracy Murphy, Jacqueline M Mason, Brian Leber, Mark R Bray, Steven M Chan, Vikas K Gupta, Dina Khalaf, Dawn Maze, Caroline J McNamara, Aaron David Schimmer, Andre C Schuh, Hassan Sibai, Michael Trus, Debbie Valiquette, Kylie Martin, Linh Nguyen, Xuan Li, Tak W Mak, Mark D Minden, Karen W L Yee
Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms. Leukemia (2023)
Tracy Murphy, Jacqueline M Mason, Brian Leber, Mark R Bray, Steven M Chan, Vikas K Gupta, Dina Khalaf, Dawn Maze, Caroline J McNamara, Aaron David Schimmer, Andre C Schuh, Hassan Sibai, Michael Trus, Debbie Valiquette, Kylie Martin, Linh Nguyen, Xuan Li, Tak W Mak, Mark D Minden, Karen W L Yee
Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms. Leukemia 38 (3) (2023)
Tracy Murphy, Jacqueline M Mason, Brian Leber, Mark R Bray, Steven M Chan, Vikas K Gupta, Dina Khalaf, Dawn Maze, Caroline J McNamara, Aaron David Schimmer, Andre C Schuh, Hassan Sibai, Michael Trus, Debbie Valiquette, Kylie Martin, Linh Nguyen, Xuan Li, Tak W Mak, Mark D Minden, Karen W L Yee
Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms. Leukemia 38 (3) (2023)
Tracy Murphy, Jacqueline M Mason, Brian Leber, Mark R Bray, Steven M Chan, Vikas K Gupta, Dina Khalaf, Dawn Maze, Caroline J McNamara, Aaron David Schimmer, Andre C Schuh, Hassan Sibai, Michael Trus, Debbie Valiquette, Kylie Martin, Linh Nguyen, Xuan Li, Tak W Mak, Mark D Minden, Karen W L Yee
Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms. Leukemia 38 (3) (2023)
Tracy Murphy, Jacqueline M Mason, Brian Leber, Mark R Bray, Steven M Chan, Vikas K Gupta, Dina Khalaf, Dawn Maze, Caroline J McNamara, Aaron David Schimmer, Andre C Schuh, Hassan Sibai, Michael Trus, Debbie Valiquette, Kylie Martin, Linh Nguyen, Xuan Li, Tak W Mak, Mark D Minden, Karen W L Yee
Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms. Leukemia 38 (3) (2023)
Tracy Murphy, Jacqueline M Mason, Brian Leber, Mark R Bray, Steven M Chan, Vikas K Gupta, Dina Khalaf, Dawn Maze, Caroline J McNamara, Aaron David Schimmer, Andre C Schuh, Hassan Sibai, Michael Trus, Debbie Valiquette, Kylie Martin, Linh Nguyen, Xuan Li, Tak W Mak, Mark D Minden, Karen W L Yee
Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms. Leukemia 38 (3) (2023)